Why the study?
Although ANP and BNP are used to diagnose heart failure in humans, reference values for heart disease had not been reported in nonhuman primates.
Are ANP and BNP levels elevated in cynomolgus monkeys with spontaneous valvular disease compared to healthy monkeys?
Are ANP and BNP levels elevated in cynomolgus monkeys with spontaneous valvular disease compared to healthy monkeys?
ANP and BNP can serve as indicators of cardiac disease in cynomolgus monkeys, validating this nonhuman primate model for human cardiology research.
ANP/BNP elevations signal valvular disease in nonhuman primates; extends biomarker data to primate models but leaves open diagnostic validation.
Nonhuman primates are commonly used as experimental animals due to their biological resemblance to humans. In patients with cardiac disease, the levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) tend to increase in response to cardiac damage, and they are thus used as indicators for the diagnosis of human heart failure. However, no reference values for ANP and BNP have been reported for heart disease in nonhuman primates. In this study, we recorded the age, sex, and body weight of 202 cynomolgus monkeys, and performed evaluations to assess the ANP and BNP levels, electrocardiography and echocardiography, and accordingly divided the monkeys into two groups: healthy monkeys and those with spontaneous cardiac disease. Statistical analysis was performed to determine the relationship of ANP and BNP with the factors of age, sex, and body weight. No significant relationship was found between the levels of ANP and BNP and the factors of age, sex, and body weight. However, both the ANP and BNP levels were significantly different between the healthy monkeys and monkeys with valvular disease. Similar to humans, the ANP and BNP levels tended to increase with the progression of cardiac disease in monkeys. Based on these results, we concluded that ANP and BNP are indicators of cardiac disease in nonhuman primates, and that this nonhuman primate cardiac disease model is applicable for cardiology research in humans.
No takes yet. Share an insight, caveat, or question.
Pai et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: